Apologies in advance for my ignorance but does anyone more knowledgeable than myself on the subject matter see potential for the FebriDx point of care test device to support COVID-19 screening?
I see that FebriDx tests to diagnose febrile acute respiratory infections (ARI) and can distinguish viral from bacterial infections but nothing further / specific to COVID-19. I have no doubt that establishing a COVID-19 point of care testing capability would be on the receiving end of some interest by the company at present.
This could prove to be a very timely Medtech IPO.
Perok
COVID-19
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.89M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.8¢ | $711 | 25.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33089 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 202037 | 2 |
View Market Depth
| Last trade - 15.54pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.8¢ | 2.8¢ | 85758 | ||
| Last updated 15.54pm 14/06/2024 ? | |||||
| AT1 (ASX) Chart |